EUVIMEDEUVIMED entdecken
Open Access

Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity

Muhetaerjiang Mamuti, Dan Zhu, Chenxi Yin, Xuejian Zhang, Qinran Yu, Zhetong Jin, Lei Jiang, Weizhi Chen, Xiqun Jiang iD

Advanced Materials · 2026-07 · 38 (38)

DOI: 10.1002/adma.73533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 01.06.2026. Verfasst von Muhetaerjiang Mamuti und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of High Performance Polymer Materials & Technology and State Key Laboratory of Analytical Chemistry For Life Science, School of Ch…. Hauptthemen laut MEDLINE: Nanovaccines, Lipopeptides, Cancer Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Basic Research Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precise control over the spatial and temporal delivery of antigens and adjuvants is essential for eliciting effective and durable immune responses. Here, we report a self‐assembling nanovaccine platform based on dendritic lipopeptides (DLPs) that integrate delivery and immune‐stimulation through a structurally defined design. DLPs are constructed by conjugating structurally optimized lipid tails to second‐generation lysine‐ or arginine‐rich dendritic scaffolds. Systematic engineering of the lipid domain allows for precise fine‐tuning of the amphiphilic structure, yielding molecular candidates with significantly enhanced TLR2/4 agonist activity. These structures facilitate antigen uptake and cross‐presentation by APCs in a spatiotemporally regulated manner. Co‐assembly with lipidated peptide antigens and a lipid‐modified TLR7/8 agonist yields nanoscale vaccines capable of orchestrating synergistic multi‐pattern recognition receptor (PRR) activation. In murine melanoma and colorectal tumor models, these nanovaccines elicit robust cytotoxic T lymphocyte responses, enhance antigen‐specific killing by up to 40%, and induce significant tumor regression. This work presents a chemically defined, modular nanoplatform that mimics key features of pathogen‐like immunity and provides a rational strategy for engineering minimalist cancer vaccines with high efficacy and translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanovaccinesLipopeptidesCancer VaccinesAnimalsMiceToll-Like Receptor AgonistsInnate Immunity RecognitionT-Lymphocytes, CytotoxicCell Line, TumorMice, Inbred C57BLProtein Subunit Vaccines

Stichwörter der Autor:innen

Multi‐TLR activationSelf‐adjuvanting materialscancer immunotherapydendritic lipopeptidesliposome nanovaccines

Substanzen

NanovaccinesLipopeptidesCancer VaccinesToll-Like Receptor AgonistsProtein Subunit Vaccines

Autor:innen und Institutionen

  • MOE Key Laboratory of High Performance Polymer Materials & Technology and State Key Laboratory of Analytical Chemistry For Life Science, School of Chemistry, Nanjing University, Nanjing, China.
  • State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Department of Oncology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing, China.

ORCID-Profile: Xiqun Jiang

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Basic Research Program of Jiangsu Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Mamuti, M., Zhu, D., Yin, C., Zhang, X., Yu, Q., Jin, Z., Jiang, L., Chen, W., & Jiang, X. (2026). Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity. Advanced Materials, 38(38). https://doi.org/10.1002/adma.73533

Vancouver

Mamuti M, Zhu D, Yin C, Zhang X, Yu Q, Jin Z, et al. Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity. Advanced Materials. 2026;38(38). doi:10.1002/adma.73533

BibTeX
@article{Mamuti2026,
  author = {Mamuti, Muhetaerjiang and Zhu, Dan and Yin, Chenxi and Zhang, Xuejian and Yu, Qinran and Jin, Zhetong and Jiang, Lei and Chen, Weizhi and Jiang, Xiqun},
  title = {Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {38},
  doi = {10.1002/adma.73533}
}
Kostenlos starten →